Prophylactic Donor Lymphocyte Infusion After T-Cell-Replete Allogeneic Hsct Prevents Disease Relapse And Prolongs Survival In Patients With High-Risk Acute Leukemia

BONE MARROW TRANSPLANTATION(2020)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要